Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109723114> ?p ?o ?g. }
- W2109723114 endingPage "1626" @default.
- W2109723114 startingPage "1621" @default.
- W2109723114 abstract "The aim of the present study was to evaluate the cerebrospinal fluid (CSF)/serum leptin ratio during pharmacological therapy for obesity with centrally and peripherally acting drugs. Thirty-one obese women (mean age, 32.3 +/- 10 yr; body mass index, 38.2 +/- 5.2 kg/m(2); body fat, 43.3 +/- 5.4%) were studied before and 2 months after a weight loss program consisting of a balanced diet (1200 kcal/d) plus drug therapy. The patients were randomly assigned into three study groups: group I, fenproporex 25 mg/d (n = 10); group II, sibutramine 10 mg/d (n = 10); and group III, orlistat 120 mg tid (n = 11). Body fat, measured by dual-energy x-ray absorptiometry, and serum and CSF concentrations of leptin were examined at baseline and 2 months after therapy. At baseline, clinical and biochemical characteristics of the groups were similar. All of the women lost weight, approximately 7.0% of their initial body weight, and the reduction was not different among the groups. Serum leptin fell significantly after 2 months in all groups, and the decline was proportional to the reduction in body fat, because leptin levels adjusted for body fat did not change after treatment. CSF leptin levels showed a significant decrease after 2 months in all groups, and this decline was higher on group III compared with group I (P = 0.006). After therapy, the CSF/serum leptin ratio did not change in group I (1.57 +/- 0.3 to 1.72 +/- 0.62%) and group II (1.78 +/- 1.01 to 1.69 +/- 1.27%), whereas it declined significantly in group III (1.65 +/- 0.43 to 1.09 +/- 0.47%; P < 0.01), corresponding to a decrease of 33.3 +/- 22.5% for the CSF/serum leptin ratio. The percentage change in group III was significantly different from the positive variation on group I (11.9 +/- 42.1%; P = 0.006) and close to the statistical significance compared with the negative variation seen in group II (-7.6 +/- 27.8%; P = 0.06). Our results showed that the CSF/serum leptin ratio decreased after weight loss in obese women treated during 2 months with orlistat, whereas this ratio did not change in this period of time in obese women treated with fenproporex and sibutramine." @default.
- W2109723114 created "2016-06-24" @default.
- W2109723114 creator A5000427697 @default.
- W2109723114 creator A5004024334 @default.
- W2109723114 creator A5044042587 @default.
- W2109723114 creator A5049647220 @default.
- W2109723114 creator A5057906313 @default.
- W2109723114 creator A5059993395 @default.
- W2109723114 date "2002-04-01" @default.
- W2109723114 modified "2023-09-26" @default.
- W2109723114 title "The Cerebrospinal Fluid/Serum Leptin Ratio during Pharmacological Therapy for Obesity" @default.
- W2109723114 cites W1489925379 @default.
- W2109723114 cites W1561443084 @default.
- W2109723114 cites W1631449371 @default.
- W2109723114 cites W1927710737 @default.
- W2109723114 cites W1973364902 @default.
- W2109723114 cites W1974760551 @default.
- W2109723114 cites W1984517734 @default.
- W2109723114 cites W2016994959 @default.
- W2109723114 cites W2024807787 @default.
- W2109723114 cites W2025846514 @default.
- W2109723114 cites W2027427622 @default.
- W2109723114 cites W2030789541 @default.
- W2109723114 cites W2032777955 @default.
- W2109723114 cites W2042535492 @default.
- W2109723114 cites W2042631625 @default.
- W2109723114 cites W2043458888 @default.
- W2109723114 cites W2059711459 @default.
- W2109723114 cites W2073850633 @default.
- W2109723114 cites W2081342783 @default.
- W2109723114 cites W2081494990 @default.
- W2109723114 cites W2087133453 @default.
- W2109723114 cites W2089431289 @default.
- W2109723114 cites W2108112873 @default.
- W2109723114 cites W2109251309 @default.
- W2109723114 cites W2125510262 @default.
- W2109723114 cites W2126326574 @default.
- W2109723114 cites W2147788805 @default.
- W2109723114 cites W2156218782 @default.
- W2109723114 cites W2327579752 @default.
- W2109723114 cites W2334034035 @default.
- W2109723114 cites W2334337188 @default.
- W2109723114 cites W3187158842 @default.
- W2109723114 doi "https://doi.org/10.1210/jcem.87.4.8420" @default.
- W2109723114 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11932292" @default.
- W2109723114 hasPublicationYear "2002" @default.
- W2109723114 type Work @default.
- W2109723114 sameAs 2109723114 @default.
- W2109723114 citedByCount "34" @default.
- W2109723114 countsByYear W21097231142012 @default.
- W2109723114 countsByYear W21097231142016 @default.
- W2109723114 countsByYear W21097231142017 @default.
- W2109723114 countsByYear W21097231142018 @default.
- W2109723114 countsByYear W21097231142022 @default.
- W2109723114 crossrefType "journal-article" @default.
- W2109723114 hasAuthorship W2109723114A5000427697 @default.
- W2109723114 hasAuthorship W2109723114A5004024334 @default.
- W2109723114 hasAuthorship W2109723114A5044042587 @default.
- W2109723114 hasAuthorship W2109723114A5049647220 @default.
- W2109723114 hasAuthorship W2109723114A5057906313 @default.
- W2109723114 hasAuthorship W2109723114A5059993395 @default.
- W2109723114 hasBestOaLocation W21097231141 @default.
- W2109723114 hasConcept C126322002 @default.
- W2109723114 hasConcept C134018914 @default.
- W2109723114 hasConcept C171089720 @default.
- W2109723114 hasConcept C2777646958 @default.
- W2109723114 hasConcept C2779651940 @default.
- W2109723114 hasConcept C2780221984 @default.
- W2109723114 hasConcept C2780613262 @default.
- W2109723114 hasConcept C2780780548 @default.
- W2109723114 hasConcept C511355011 @default.
- W2109723114 hasConcept C544821477 @default.
- W2109723114 hasConcept C71924100 @default.
- W2109723114 hasConceptScore W2109723114C126322002 @default.
- W2109723114 hasConceptScore W2109723114C134018914 @default.
- W2109723114 hasConceptScore W2109723114C171089720 @default.
- W2109723114 hasConceptScore W2109723114C2777646958 @default.
- W2109723114 hasConceptScore W2109723114C2779651940 @default.
- W2109723114 hasConceptScore W2109723114C2780221984 @default.
- W2109723114 hasConceptScore W2109723114C2780613262 @default.
- W2109723114 hasConceptScore W2109723114C2780780548 @default.
- W2109723114 hasConceptScore W2109723114C511355011 @default.
- W2109723114 hasConceptScore W2109723114C544821477 @default.
- W2109723114 hasConceptScore W2109723114C71924100 @default.
- W2109723114 hasIssue "4" @default.
- W2109723114 hasLocation W21097231141 @default.
- W2109723114 hasLocation W21097231142 @default.
- W2109723114 hasOpenAccess W2109723114 @default.
- W2109723114 hasPrimaryLocation W21097231141 @default.
- W2109723114 hasRelatedWork W2025688934 @default.
- W2109723114 hasRelatedWork W2025731911 @default.
- W2109723114 hasRelatedWork W2077675220 @default.
- W2109723114 hasRelatedWork W2099969362 @default.
- W2109723114 hasRelatedWork W2106570883 @default.
- W2109723114 hasRelatedWork W2325999202 @default.
- W2109723114 hasRelatedWork W2348811830 @default.
- W2109723114 hasRelatedWork W38646089 @default.
- W2109723114 hasRelatedWork W4242900151 @default.